The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides - doi.org/10.3899/jrheum.2025-0481
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0482
Differences in Cause-Specific Mortality in Patients With Rheumatoid Arthritis by Sex and Seropositivity - doi.org/10.3899/jrheum.2025-0361
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - doi.org/10.3899/jrheum.2024-1013
Effect of Knee Extensor Power on Knee Pain in Adults With or at Risk for Osteoarthritis: The Multicenter Osteoarthritis Study - doi.org/10.3899/jrheum.2025-0621
COVID-19 Vaccine Booster Uptake and Effectiveness Among Persons With Systemic Autoimmune and Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0535
All content for The JRHEUM Podcast is the property of The Journal of Rheumatology and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides - doi.org/10.3899/jrheum.2025-0481
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0482
Differences in Cause-Specific Mortality in Patients With Rheumatoid Arthritis by Sex and Seropositivity - doi.org/10.3899/jrheum.2025-0361
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - doi.org/10.3899/jrheum.2024-1013
Effect of Knee Extensor Power on Knee Pain in Adults With or at Risk for Osteoarthritis: The Multicenter Osteoarthritis Study - doi.org/10.3899/jrheum.2025-0621
COVID-19 Vaccine Booster Uptake and Effectiveness Among Persons With Systemic Autoimmune and Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0535
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Changes at Presentation in Patients With Early Rheumatoid Arthritis: A 24-Year Study of the Early Undifferentiated Polyarthritis (EUPA) Cohort - doi.org/10.3899/jrheum.2024-0560
Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis - doi.org/10.3899/jrheum.2024-0653
The Lived Experiences of Older Adults With Systemic Lupus Erythematosus: Patient Perspectives - doi.org/10.3899/jrheum.2024-0478
Symptom Severity and Glucocorticoid Dosing in Patients With Polymyalgia Rheumatica and Obesity - doi.org/10.3899/jrheum.2024-0353
Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis - doi.org/10.3899/jrheum.2024-0538
The JRHEUM Podcast
The Journal of Rheumatology's Editor-in-Chief Earl Silverman discusses this month's selection of articles that are most relevant to the clinical rheumatologist.
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides - doi.org/10.3899/jrheum.2025-0481
Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0482
Differences in Cause-Specific Mortality in Patients With Rheumatoid Arthritis by Sex and Seropositivity - doi.org/10.3899/jrheum.2025-0361
Diversity in Axial Spondyloarthritis Drug Trials: Enrollment by Sex, Race, Ethnicity, and Geographic Region - doi.org/10.3899/jrheum.2024-1013
Effect of Knee Extensor Power on Knee Pain in Adults With or at Risk for Osteoarthritis: The Multicenter Osteoarthritis Study - doi.org/10.3899/jrheum.2025-0621
COVID-19 Vaccine Booster Uptake and Effectiveness Among Persons With Systemic Autoimmune and Rheumatic Diseases - doi.org/10.3899/jrheum.2025-0535
